PATH UiPath Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
16:20
Aug 18
Aug 18
Takeover candidates GitLab, UiPath, PTC, Procore.
KeyBanc highlighted GitLab, UiPath, PTC, and Procore as potential software takeover candidates because a Workday deal could set a floor for other software names and spark buyout interest.
MED
07:39
Jul 23
Jul 23
Watch PATH as Google's agentic AI and Gemini Enterprise pose high negative risk to traditional.
Watch PATH as Google's agentic AI and Gemini Enterprise pose high negative risk to traditional RPA; automation shifting to platform feature.
MED
21:45
Jun 27
Jun 27
UiPath’s management acknowledged that current per‑platform unit pricing slows adoption; they plan to transition to AI credits / outcome‑based pricing (Q4 FY26 earnings). A licensing shift would remove a key friction point, enabling faster upselling to Fortune 500 clients and boosting consumption‑based revenue, potentially accelerating RPO and NDR growth. If UiPath successfully flattens revenue lumpiness with standardized vertical “AI Playbooks” and more flexible pricing, the stock could re‑rate higher as the market recognizes a sustainable growth trajectory. Execution risk on pricing transition; competition from larger AI platform players; DoD deals may be lumpy; top comment indicates bag‑holders wanting to exit, suggesting weak near‑term momentum.
HIGH
16:36
Jun 15
Jun 15
The tweet suggests a playful rename for UiPath to AIPath.
The tweet suggests a playful rename for UiPath to AIPath, but lacks any explicit position or forward-looking trade call.
LOW
20:13
May 28
May 28
UiPath reports first quarter fiscal 2026 earnings with revenue up 17 percent year-over-year.
UiPath reports first quarter fiscal 2026 earnings with revenue up 17 percent year-over-year and ARR reaching 1.901 billion dollars.
16:50
May 28
May 28
PATH holds $1.5B cash, trades at ~4x last year’s revenue, and just posted its first positive EPS; 30% of float is short. The combination of undervaluation, accelerating enterprise AI adoption, and high short interest creates a squeeze/rerating opportunity. Buy calls (Jan ’27 $15c) to play medium-term growth and potential gamma/squeeze on earnings. Earnings miss, competition from other automation/AI integration platforms, macro-driven tech selloff, or failure to convert growth into sustained profitability.
HIGH
13:10
Apr 04
Apr 04
The author argues UiPath is significantly undervalued due to its large cash balance.
The author argues UiPath is significantly undervalued due to its large cash balance, presenting a clear long opportunity.
MED
11:10
Apr 03
Apr 03
The author recommends buying PATH as it is trading at a 40% discount.
The author recommends buying PATH as it is trading at a 40% discount, implying significant upside.
HIGH
14:36
Mar 30
Mar 30
Heavily corrected stocks are showing resilience and reduced selling pressure during broader.
Heavily corrected stocks are showing resilience and reduced selling pressure during broader market weakness.
00:54
Mar 28
Mar 28
The tweet highlights significant year-to-date losses for five stocks.
The tweet highlights significant year-to-date losses for five stocks, casting doubt on their current valuation.
15:45
Mar 12
Mar 12
Companies that use AI to automate tasks for the better — service-based ideas.
Companies that use AI to automate tasks for the better — service-based ideas; $PATH listed as one to invest in.
MED
13:45
Mar 12
Mar 12
The author suggests that even with decent earnings.
The author suggests that even with decent earnings, the fundamental long-term bull case for the stock is weak, implying it is not a buy and is likely to underperform.
MED
11:22
Mar 12
Mar 12
"UiPath, a software company... down by 5%... back to some growth prospect concerns by Bloomberg Intelligence." In a macro environment plagued by high rates and geopolitical uncertainty, enterprise software companies with decelerating growth are heavily penalized. As corporations scrutinize IT budgets and shift spending toward pure-play generative AI, legacy automation software names will suffer severe multiple compression. SHORT. Weakening growth prospects in a risk-off macro environment make mid-tier software highly vulnerable. A broader tech sector rally, a surprise earnings beat, or an acquisition offer could force a rapid short squeeze.
07:10
Mar 12
Mar 12
The company is providing strong forward guidance for significant revenue growth and margin.
The company is providing strong forward guidance for significant revenue growth and margin expansion, driven by the secular trend of AI adoption.
MED
20:37
Mar 11
Mar 11
UiPath reports strong Q4 earnings beat
Reports UiPath Q4 earnings and revenue beats across the board, no directional view stated.
LOW
20:12
Mar 11
Mar 11
UiPath reports solid year-over-year growth in revenue and ARR alongside strong gross margins.
12:12
Mar 10
Mar 10
NVDA validates PATH's agentic orchestration pivot
Buy PATH ahead of Wednesday earnings — Nvidia's NemoClaw platform validates UiPath's Maestro agentic orchestration layer, confirming the strategic pivot from legacy RPA and accelerating enterprise AI agent adoption, which the market is misreading as bearish competition.
MED
21:56
Mar 06
Mar 06
"UI path, some others that have maybe more one trick pony business models that could be disintermediate." Unlike Salesforce or Microsoft (which own the data), UiPath focuses on task automation (RPA). Ives implies that Generative AI agents can inherently perform these tasks without needing specialized RPA software, making their business model existentialy vulnerable. AVOID (or SHORT). Differentiate them from the "winners" in the software stack. UiPath successfully pivots to becoming an AI-agent orchestrator, proving the bear case wrong.
19:31
Mar 05
Mar 05
Highlights UiPath RPA integration with Uber
Highlights UiPath's RPA integration with Uber, driving significant cost savings and automation of invoicing.
MED
14:38
Mar 05
Mar 05
Barkin attributes the impressive 2.8% productivity number to companies that "invested in new processes, new staffing models, automation" and "AI" because they were caught short of workers three years ago. The "Productivity" Barkin praises is not magic; it is Capex spending. Companies are buying hardware (Rockwell), software (Microsoft), and automation tools (UiPath) to protect margins. If the Fed sees this as the solution to inflation, corporate spend will continue to funnel here. LONG. This is a structural play on the "Margin Protection" trade. Tech valuation compression if interest rates spike due to the oil shock.
00:44
Feb 07
Feb 07
UiPath (Robotic Process Automation). The stock is too expensive, and the thesis that bots will replace mundane tasks is not compelling enough to justify the valuation.
14:21
Jan 16
Jan 16
Speaker references $ZETA and $PATH as past trend picks by another user.
Speaker references $ZETA and $PATH as past trend picks by another user, no directional view or position stated.
LOW
20:45
Jan 13
Jan 13
PATH -8.5% on Claude co-work model launch
PATH dropped 8.5% following Anthropic's Claude co-work model announcement, which the speaker flags as a potential overreaction; no explicit directional commitment made.
LOW
18:06
Jan 12
Jan 12
PATH on author's watchlist, no thesis stated
Author places PATH on watchlist with no directional commitment or specific catalyst stated; monitoring only.
LOW
17:20
Jan 08
Jan 08
PATH named robotics second-wave pick
Co-mentioned as a robotics sector beneficiary in a thematic capital-flow prediction, framed as second-wave recipient after AI capital fuels robotics breakthroughs.
MED
18:07
Jan 07
Jan 07
PATH long on AI-driven RPA scaling
Buy PATH as a long-term structural bet on RPA scaling driven by AI-driven automation demand, which author argues is multi-decade and currently underpriced by the market.
MED
18:22
Jan 03
Jan 03
PATH on 2026 watchlist for enterprise RPA
Author flags PATH as a 2026 watchlist addition, citing enterprise robotic process automation scaling as the rationale; no position initiated yet.
MED
20:45
Jan 02
Jan 02
Included in 2026 watchlist
Author includes PATH in their 2026 watchlist, asking which will outperform.
LOW
About PATH Analyst Coverage
Buzzberg tracks PATH (UiPath Inc.) across 12 sources. 10 bullish vs 2 bearish calls from 17 analysts. Sentiment: predominantly bullish (25%). 32 total trade ideas tracked. Latest voices: Deirdre Bosa, TheValueist, u/correa_aesth.